High-Throughput Metabolomics for Discovering Potential Biomarkers and Identifying Metabolic Mechanisms in Aging and Alzheimer’s Disease
| Autor: | Zhiping Long, Qi Qin, Chenghai Peng, Zhen Wu, Kun Xie, Yihui Yang, Volontovich Daria, Fan Wang, Liangliang Li, Maoqing Wang, Yashuang Zhao, Chunyang Xi |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
education.field_of_study
Arginine Mechanism (biology) Metabolite aging Population Cell Biology Disease Computational biology Biology metabolomics Citric acid cycle Cell and Developmental Biology chemistry.chemical_compound mild cognitive impairment Metabolomics lcsh:Biology (General) chemistry metabolic biomarkers Purine metabolism education lcsh:QH301-705.5 Alzheimer’s disease Original Research Developmental Biology |
| Zdroj: | Frontiers in Cell and Developmental Biology Frontiers in Cell and Developmental Biology, Vol 9 (2021) |
| ISSN: | 2296-634X |
| Popis: | Background and Aims: Alzheimer’s disease (AD) is an aging-related neurodegenerative disease. The current diagnosis of AD may fail to identify a substantial number of asymptomatic individuals who will progress to AD. We aimed to investigate the metabolic mechanisms of aging and AD and to identify potential biomarkers for the early screening of AD in a natural aging population.Methods: To analyse the plasma metabolites related to aging, we conducted an untargeted metabolomics analysis using ultra-high-performance liquid chromatography/quadrupole time-of-flight mass spectrometry in a two-stage cross-sectional study. Spearman’s correlation analysis and random forest were applied to model the relationship between age and each metabolite. Moreover, systematic reviews of metabolomics studies of AD in the PubMed, Cochrane and Embase databases were searched to extract the differential metabolites and altered pathways from original studies. Pathway enrichment analysis was conducted using Mummichog.Results: In total, 669 metabolites were significantly altered with aging, and thirteen pathways were enriched and correlated with aging. Five metabolites (palmitic acid, stearic acid, linoleic acid, glutamine, and oleic acid) were identified as potential biomarkers for AD based on a systematic review. Arginine and histidine were considered candidate monitoring markers of disease progression in the mild cognitive impairment (MCI) population. Moreover, three pathways (purine metabolism, arginine and proline metabolism, and the TCA cycle) were shared between aging and AD. Arginine and proline metabolism play a key role in the progression from CN to MCI and to AD in the natural aging population. Three metabolites, 16-a-hydroxypregnenolone, stearic acid and PC (16:0/22:5(4Z,7Z,10Z,13Z,16Z)), were finally proposed as potential markers of AD in the natural aging population.Conclusion: The underlying mechanism shared between aging and AD and the potential biomarkers for AD diagnosis were proposed based on multistep comparative analysis. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|